SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is trending as a high-volatility, low-float momentum play that community members are aggressively trading as a potential short squeeze candidate. Traders are actively debating whether this is a sustainable rally or a pump-and-dump, focusing on elevated cost-to-borrow rates and the stock's tendency for rapid, multi-day spikes reminiscent of past microcap runners.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing heavy selling pressure after raising its full-year capital expenditure guidance to support AI infrastructure, despite delivering strong revenue growth and earnings beats. Investors remain deeply divided, with many expressing frustration over the persistent spending cycle while others view the dip as a tactical buying opportunity in a growth-focused leader.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is surging on momentum fueled by an alliance with Musk's TERAFAB and strong political endorsements, driving intense community debate over whether it is a legitimate turnaround or a speculative bubble. While bulls are celebrating the companys revaluation as a critical domestic AI infrastructure play, many traders are warning of a potential 'pump and dump' setup and cautioning against chasing the rapid climb.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors react to reports of a custom AI chip partnership with Marvell, while community sentiment remains focused on the company's aggressive infrastructure spending and Cloud growth ahead of earnings.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors aggressively position themselves ahead of its highly anticipated earnings report, with the community closely watching whether Google Cloud's recent growth and AI integration can justify the company's massive capital expenditure. While the broader market remains cautious due to macroeconomic uncertainty, sentiment around the stock is heavily bullish, fueled by institutional accumulation and the expectation that Alphabet will solidify its competitive standing in the ongoing AI infrastructure arms race.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as investors weigh strong underlying fundamentals, including significant defense contract wins and active share buybacks, against short-term macro headwinds caused by regional conflict. The community remains highly focused on the company's pivot toward nuclear energy via Small Modular Reactors (SMRs) and its broader role in global energy security.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened anticipation ahead of upcoming earnings, with investors closely watching for updates on the Phase 3 obesity program and potential pipeline expansions. The community remains focused on the long-term potential of its dual agonist VK2735, debating whether standalone development or a major partnership/buyout represents the most viable path to unlocking value.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a surge in investor attention driven by sector-wide momentum as competitors like Bloom Energy announce significant data center partnerships, highlighting a growing market demand for reliable, on-site power solutions. The community is actively discussing the potential for a long-awaited contract or deal that could serve as a catalyst for a re-rating, though sentiment remains tempered by ongoing concerns regarding share dilution and management's execution track record.

Goldfinch is a DeFi protocol that brings crypto loans to the real world.

Goldfinch

Goldfinch is seeing renewed market attention as traders highlight its role in the Real World Asset sector and its low circulating supply, with many discussing potential for significant gains alongside other major RWA projects. While some community members remain skeptical of its price action and label it volatile, others are aggressively accumulating during pullbacks, citing long-term utility and institutional connections as key drivers for future upside.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is surging as investors react to reports of a potential partnership with OpenAI to develop specialized chips for AI-enabled smartphones. While the community is actively debating the sustainability of this price move versus the upcoming earnings report, many are framing the stock as an undervalued play within the broader semiconductor sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Editas Medicine (NASDAQ:EDIT) Share Price Passes Above 50 Day Moving Average - Here's What Happened

Editas Medicine (NASDAQ:EDIT) Stock Passes Above Fifty Day Moving Average - Should You Sell...

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Black Diamond (BDTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) have received an average rating of "Moderate Buy" from the eight brokerages that are covering the firm, MarketBeat reports. One analyst...

Editas Medicine (NASDAQ:EDIT) Downgraded by Wall Street Zen to Sell

Wall Street Zen cut Editas Medicine from a "hold" rating to a "sell" rating in a report on Saturday...

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Research Weighs in on Editas Medicine FY2028 Earnings

Editas Medicine, Inc. (NASDAQ:EDIT - Free Report) - Analysts at Zacks Research issued their FY2028 earnings estimates for Editas Medicine in a note issued to investors on Monday, March 23rd. Zacks...

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have...

Is Editas Medicine Going to $0?

Key PointsEditas Medicine has been on fire over the trailing-12-month period...

Editas Medicine Details In Vivo CRISPR Plan, Targets Year-End Human Proof-of-Concept for EDIT-401

Editas Medicine (NASDAQ:EDIT) executives outlined the company's in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore...

Editas Medicine (NASDAQ:EDIT) Upgraded at JonesTrading

JonesTrading raised shares of Editas Medicine from a "hold" rating to a "buy" rating and set a $8.00 price objective on the stock in a research note on Tuesday...

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Editas Medicine Inc

$GOOGL

$MSFT

$AMZN

$META

Which Mag 7 name makes the biggest move after earnings today?

EDIT
Editas Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest EDIT News

EDITEditas Medicine Inc